Arrakis Therapeutics is a pioneering biotechnology company based in Waltham, MA, dedicated to revolutionizing the field of RNA-targeted small molecule therapeutics. With a focus on the development of rSM medicines, Arrakis is committed to identifying novel RNA degrader small molecule therapeutics through collaborations with partners like Amgen.
Driven by a fearless and resilient mission, Arrakis is on an expedition to improve patients' lives by exploring the RNA lifecycle and unlocking the potential of rSM medicines. Through their Dark Matter Blog, the company shares insights from their leaders and scientists, providing a glimpse into the progress made in the quest for RNA-targeted small molecules.
Generated from the website